Navigation Links
When to Have That Joint Replacement?

Some minority groups wait too long for surgery, study finds

LAS VEGAS, Feb. 25 /PRNewswire-USNewswire/ -- Hispanic and African-American patients tend to have poorer joint function before undergoing hip or knee replacement surgery, according to a new study presented today at the 2009 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) ( In addition, female patients have less preoperative joint function than male patients across ethnic groups.

"Studies have shown that the timing of joint replacement surgery ( is an important determinant of outcome," says James Slover, M.D., M.S., an orthopaedic surgeon at New York University Hospital for Joint Diseases. "This means that patients with worse joint function before surgery do not do as well after the surgery."

Researchers reviewed the pre-surgical joint function of more than 3,500 hip and knee replacement patients based on physical exams and questionnaires. This information comprises the functional components of the Harris Hip Score and the Knee Society Score, which were used to quantify the functional ability of all the patients. They found:

  • Even when adjusted for patient age, Hispanic and African-American patients had worse joint function before the surgery.
  • In particular, Hispanic men had worse function prior to knee and hip replacement than both African-American and Caucasian men.
  • Hispanic and African-American women had significantly worse function prior to hip replacement than Caucasian women.
  • Women demonstrated lower preoperative hip and knee function when compared with men of the same ethnicity.

The reasons for these disparities, Dr. Slover says, are unclear.

"As a next step, we need to try and understand why certain groups tend to wait longer before having surgery," he says. "Do they have less access to the necessary care? Is it an insurance issue? Is there something in their culture or mindset that makes them wait longer before pursuing treatment?

We need to know why this occurs, because if it is an issue of outreach and education, we as orthopaedic surgeons can help address the problem and help patients get the appropriate care and treatment."

Joint replacement, also known as arthroplasty, is considered by many to be one of the most successful medical innovations of the 20th century. Total joint replacement is a surgical procedure in which the patient's natural joint is replaced with an artificial one, made of a combination of plastic, metal, and/or ceramic.

The most common reasons for this surgery are pain and stiffness that limit normal activities such as walking and bending and that cannot be satisfactorily treated with medications or other therapies. Therefore, joint replacement surgery often provides a significantly improved quality of life to patients who would otherwise have to live with severe pain.

More than 400,000 primary total hip and knee replacements are performed each year in the United States, and that number is on the rise -- particularly as the Baby Boomer population continues to age. Because of this trend, it is important to optimize patient outcomes.

Disclosure: Dr. Slover and his co-authors received no compensation for this study.

Poster presentation information


Total hip replacement


Total knee replacement


About AAOS

    For more information, contact:

    Catherine Dolf
    C (847) 894-9112
    O (847) 384-4034

    Lauren L. Pearson
    C (224) 374-8610
    O (847) 384-4031

SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
2. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
3. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
4. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
5. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
6. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
7. Joint Commission Urges Patients to Speak Up About Pain
8. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015   HeartWare International, Inc ... less-invasive, miniaturized circulatory support technologies that are revolutionizing the ... and Chief Executive Officer Doug Godshall is ... Annual Healthcare Conference on December 1, 2015 at ... 1-2 in New York . ...
(Date:11/24/2015)... November 24, 2015 F1000Workspace - ... - since it was launched just six months ago. ... and authoring platform for scientists - since it was launched ... have been loaded on to F1000Workspace - a ... since it was launched just six months ago. ...
(Date:11/24/2015)... iRhythm Technologies, Inc. , a leading digital health care solutions ... participate in the 27th Annual Piper Jaffray Healthcare Conference at The ... . Kevin King , Chief Executive Officer of iRhythm, ... ET. --> --> About ... . --> iRhythm is a privately held digital ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 25, 2015 , ... Catalent Pharma Solutions, the leading ... health and global clinical supply services, today announced that Dr. Christine Milligan, Global ... Asia Conference, to be held at the InterContinental Seoul COEX Hotel, Seoul, Republic ...
(Date:11/24/2015)... ... November 24, 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy ... , FDA has long asserted that design and manufacture of Laboratory Developed ... and do not meet the device regulations. , Come up short in an inspection ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Bolier Reactor System. Brillouin is the developer of renewable energy technologies capable of ... nuclear reactions (“LENR”), announced today that its WET™ and HHT™ Boiler System reactor ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... gather to share their knowledge and experiences at a live taping of the ... Ruesch Center for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Serenity Point Rehabilitation, ... series of recent video interviews with some of the staff members at their recovery ... residential treatment facility, as well as some of the things that make their recovery ...
Breaking Medicine News(10 mins):